Loren Bartels, MD
Otology & Neurotology · Tampa, FLNPI 1619927845
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $15,964 of the $16,224 with a category attached, or 98.4%. Grace Medical, Inc. accounts for 98.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $10,557 and has fallen 99.7% since, to $28 in 2024.
Across 20 payments — averaging $811.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grace Medical, Inc.$16K
- Cochlear Americas$135
- Advanced Bionics, LLC$58
- Stryker$54
- Acclarent, Inc$13
Across 11 payments — averaging $1743.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Advanced Bionics, LLC$19K
What the payments were for
- Royalty or licence$15,96498%
- Consulting fees$120%
- Food & beverage$2482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grace Medical, Inc. | 10 | $15,964 |
| Cochlear Americas | 3 | $135 |
| Advanced Bionics, LLC | 3 | $58 |
| Stryker | 3 | $54 |
| Acclarent, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,224 in reported general payments places this provider in the 75th percentile of 25 otology & neurotology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 398 | $49,756 |
| Acyclovir | 354 | $12,498 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 115 | $8,841 |
| Famciclovir | 42 | $6,522 |
| Ondansetron OdtOndansetron | 144 | $2,542 |
| Ciprofloxacin Hcl | 90 | $1,770 |
| Acetazolamide | 23 | $1,458 |
| Hydroxychloroquine Sulfate | 23 | $1,300 |
| Topiramate | 24 | $1,273 |
| Meclizine Hcl | 87 | $1,182 |
| Ofloxacin | 35 | $1,051 |
| Nortriptyline Hcl | 48 | $941 |
| Scopolamine | 66 | $843 |
| Zonisamide | 40 | $804 |
| Clonazepam | 30 | $679 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in Tampa
- Kyle AllenTampa$14K
- Mickie HamiterTampa$7K
- Christopher DannerTampa$593
- Thomas BalkanyMiami$534K
- Simon AngeliMiami$32K
- Fred TelischiMiami$29K
- Herbert SilversteinSarasota$18K
- Jack WazenSarasota$16K
- Joshua LightBoynton Beach$12K
- Andrew MarloweSarasota$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.